You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 6, December 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PROCEDURE FOR EVALUATING SKIN-SENSITIZING POWER OF NEW MATERIALS

MATTHEW J. BRUNNER, M.D.; ADELAIDE SMILJANIC, B.S.

AMA Arch Derm Syphilol. 1952;66(6):703-705.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WITH THE accelerated development of new drugs, cosmetics, dyes, and other materials which may contact the skin, there is an increased need for rapid screening methods for evaluating their sensitizing potentials. Animal tests have little utility, mainly because of species differences in sensitizability. The prophetic patch test procedure suggested by Schwartz and Peck1 is of value but in some aspects is not entirely adequate for the purpose. In this test, the new material is applied to the skin for 48 hours under an occlusive patch; a group of 200 or more persons is used. The same group is retested in 14 to 21 days; new reactors are deemed to have been sensitized by the first patch test.

Among problems encountered in carrying out this test is, first, the difficulty in distinguishing between allergic and primary irritant patch reactions. With threshold irritants, there may be variation from time to time . . . [Full Text PDF of this Article]


Author Affiliations

CHICAGO

From the Department of Dermatology, University of Illinois College of Medicine, Francis E. Senear, M.D., Chairman (Dr. Brunner), and the Toni Research Laboratories, Chicago (Miss Smiljanic).


Footnotes

This study was supported in part by a grant from the Toni division of the Gillette Safety Razor Co.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.